This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy | MicrobiomeTrials
← Back to trials NCT05646862
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2023-06-07Est. Completion: 2026-11-13
Enrollment target: 420 participantsLocations Cancer Blood and Specialty Clinic, Los Alamitos, California, United States Los Angeles Cancer Network, Los Angeles, California, United States UC Davis Comprehensive Cancer Center, Sacramento, California, United States Rocky Mountain Cancer Centers, Denver, Colorado, United States Cleveland Clinic Florida, Weston, Florida, United States Grady Health System, Atlanta, Georgia, United States Midtown West Medical, Atlanta, Georgia, United States Emory University Hospital, Atlanta, Georgia, United States Winship Cancer Institute at Emory Saint Joseph's Hospital, Atlanta, Georgia, United States Massachusetts General Hospital, Boston, Massachusetts, United States Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States Minnesota Oncology Hematology, Saint Paul, Minnesota, United States Asante Rogue Regional Medical Center, Medford, Oregon, United States Texas Oncology - Dallas Presbyterian Hospital, Dallas, Texas, United States Centro de Investigaciones Médicas y Desarrollo LC S.R.L, Buenos Aires, Argentina Other microbiome trials you might be interested in Stage II Gallbladder Cancer AJCC v8 Stage IIA Gallbladder Cancer AJCC v8 Stage IIB Gallbladder Cancer AJCC v8 Stage III Gallbladder Cancer AJCC v8 Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIB Gallbladder Cancer AJCC v8
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (…
Birmingham, United States Est. completion Jul 1, 2028
Anatomic Stage IV Breast Cancer AJCC v8 Breast Carcinoma
Centro Oncologico Korben, Ciudad Autonoma Buenos Aires, Argentina
Fundacion CORI para la Investigacion y Prevencion del Cancer, La Rioja, Argentina
Instituto de Oncología de Rosario, Rosario, Argentina
Hosp Provincial D. Centenarios, Rosario, Argentina
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica, San Juan, Argentina
Clinica Viedma S.A., Viedma, Argentina
Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia
Concord Repatriation General Hospital, Concord, New South Wales, Australia
Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia
Gosford Hospital, Gosford, New South Wales, Australia
Icon Cancer Care Wesley, Auchenflower, Queensland, Australia
Bendigo Cancer Centre, Bendigo, Victoria, Australia
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Cliniques Universitaires St-Luc, Brussels, Belgium
GHdC Site Les Viviers, Charleroi, Belgium
UZ Antwerpen, Edegem, Belgium
UZ Gent, Ghent, Belgium
UZ Leuven Gasthuisberg, Leuven, Belgium
Clinique Ste-Elisabeth, Namur, Belgium
NUPEC, Belo Horizonte, Minas Gerais, Brazil
Hospital Santa Cruz / Centro de Oncologia D'Or, Curitiba, Paraná, Brazil
Hospital do Cancer de Pernambuco - HCP, Recife, Pernambuco, Brazil
Instituto D?Or de Pesquisa e Ensino ? Hospital Esperança Recife, Recife, Pernambuco, Brazil
Liga Norte Riograndense Contra O Câncer, Natal, Rio Grande do Norte, Brazil
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto, São Paulo, Brazil
Hospital Sírio-Libanês, São Paulo, São Paulo, Brazil
Arthur J.E. Child Comprehensive Cancer Center-Calgary, Calgary, Alberta, Canada
Cross Cancer Institute, Edmonton, Alberta, Canada
BC Cancer ? Vancouver, Vancouver, British Columbia, Canada
The Moncton Hospital, Moncton, New Brunswick, Canada
Juravinski Hospital, Hamilton, Ontario, Canada
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
CIUSSS de l Est de l Ile de Montreal - Hopital Maisonneuve Rosemont, Montreal, Quebec, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada
Jewish General Hospital, Montreal, Quebec, Canada
Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec, Canada
The First Hospital of Jilin University, Changchun, China
Sichuan Provincial Cancer Hospital, Chengdu, China
Sun yat-sen University Cancer Center, Guangzhou, China
Guangdong Provincial People's Hospital, Guangzhou, China
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
Sir Run Run Shaw Hospital Zhejiang University, Hangzhou, China
Harbin Medical University Tumor Hospital, Harbin, China
The Second Affiliated Hospital to Nanchang University, Nanchang, China
Jiangsu Cancer Hospital, Nanjing, China
Tianjin Cancer Hospital, Tianjin, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China
Hubei Cancer Hospital, Wuhan, China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, China
Zhejiang Cancer Hospital, Zhejiang, China
Centre Hospitalier de La Cote Basque, Bayonne, France
Centre Leon Berard, Lyon, France
ICM, Montpellier, France
Centre Eugene Marquis, Rennes, France
IUCT Oncopole, Toulouse, France
Uniklinik RWTH Aachen Klinik für Gynäkologie und Geburtsmedizin, Aachen, Germany
Universitätsklinikum Essen, Essen, Germany
Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, Freiburg im Breisgau, Germany
Universitätsmedizin Göttingen Georg-August-Universität, Göttingen, Germany
Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg, Germany
Medizinische Hochschule Zentrum Frauenheilkunde Abt.Gynäkologische Onkologie, Hanover, Germany
Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Germany
Brustzentrum Rhein-Ruhr Servicegesellschaft mbH, Mönchengladbach, Germany
St. Vincenz-Krankenhaus GmbH Paderborn Frauen- und Kinderklinik St. Louise, Paderborn, Germany
A.O. S. Anna e San Sebastiano, Caserta, Campania, Italy
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola, Emilia-Romagna, Italy
Ospedale San Raffaele, Milan, Lombardy, Italy
Ospedale Santa Chiara, Trento, Trentino-Alto Adige, Italy
Panamerican Clinical Research S.A de C.V., Guadalajara, Jalisco, Mexico
RENATI INNOVATION S.A.P.I. de C.V, Guadalajara, Jalisco, Mexico
COI Centro Oncologico Internacional Santa Fe, Mexico City, Mexico CITY (federal District), Mexico
Health Pharma Professional Research, Mexico City, Mexico CITY (federal District), Mexico
OncoMed, Mexico City, Mexico CITY (federal District), Mexico
ARKE Estudios Clínicos S.A. de C.V., Mexico City, Mexico CITY (federal District), Mexico
Instituto Nacional de Cancerologia, Distrito Federal, Mexico
CENEIT Oncologicos, Mexico City, Mexico
Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Morelia, Mexico
New Zealand Clinical Research - Auckland, Auckland, New Zealand
Centrum Onkologii im. Prof. Franciszka ?ukaszczyka, Bydgoszcz, Poland
Narodowy Instytut Onkologii Odzia? w Gliwicach, Gliwice, Poland
Przychodnia Lekarska KOMED, Roman Karaszewski, Konin, Poland
Szpital Wojewódzki im. Miko?aja Kopernika, Koszalin, Poland
Szpital Uniwersytecki w Krakowie, Krakow, Poland
MRUKMED Lekarz Beata Madej-Mruk i Partner Spolka Partnerska Oddzial nr 1 w Rzeszowie, Rzeszów, Poland
Narodowy Instytut Onkologii im. M.Sklodowskiej-Curie, Warsaw, Poland
Medical Oncology Centre of Rosebank, Johannesburg, South Africa
Richards Bay Oncology Centre, KwaZulu Natal, South Africa
Kyungpook National University Chilgok Hospital, Daegu, South Korea
National Cancer Center, Goyang-si, South Korea
Korea University Anam Hospital, Seoul, South Korea
Seoul National University Hospital, Seoul, South Korea
Severance Hospital, Yonsei University Health System, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Gangnam Severance Hospital, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Seoul St Mary's Hospital, Seoul, South Korea
ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario de Canarias, San Cristóbal de La Laguna, Tenerife, Spain
Hospital San Pedro De Alcantara, Cáceres, Spain
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Hospital Ramon y Cajal, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Regional Universitario Carlos Haya, Málaga, Spain
Hospital Universitario Virgen Macarena, Seville, Spain
China Medical University Hospital, Taichung, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Chang Gung Memorial Hosipital at Linkou, Taoyuan City, Taiwan
Veterans General Hospital - Taichung, Xitun Dist., Taiwan
National Taiwan University Hospital, Zhongzheng Dist., Taiwan
Gulhane Training and Applicaton Hospital, Ankara, Turkey (Türkiye)
Memorial Ankara Hastanesi, Ankara, Turkey (Türkiye)
Dicle University Faculty of Medicine, Diyarbakır, Turkey (Türkiye)
Trakya University Medical Faculty, Edirne, Turkey (Türkiye)
Medipol Mega Üniversite Hastanesi Göztepe, Istanbul, Turkey (Türkiye)
Marmara Uni Faculty of Medicine, Istanbul, Turkey (Türkiye)
Ege Uni Medical Faculty Hospital, Izmir, Turkey (Türkiye)
Izmir Ataturk Training and Research Hospital, Izmir, Turkey (Türkiye)
Goztepe Prof.Dr. Suleyman Yalcin City Hospital, Kadiköy, Turkey (Türkiye)
Hacettepe Uni Medical Faculty Hospital, Sihhiye/Ankara, Turkey (Türkiye)
Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom
Blackpool Victoria Hospital, Blackpool, United Kingdom
Western General Hospital, Edinburgh, United Kingdom
Princess Alexandra Hospital, Harlow, United Kingdom
St Bartholomew's Hospital, London, United Kingdom
Maidstone & Tonbridge Wells Hospital, Maidstone, United Kingdom
Mount Vernon & Watford Hospital Trust, Northwood, United Kingdom
Churchill Hospital, Oxford, United Kingdom
Royal Hampshire County Hospital, Winchester, United Kingdom HER2-Negative Breast Carcinoma
Hormone Receptor-Positive Breast Carcinoma
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a me…
Fairbanks, United States Est. completion Jul 31, 2027
Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax …
Birmingham, United States Est. completion Oct 1, 2028